NM_001330260.2:c.1999-5delT

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6

The NM_001330260.2(SCN8A):​c.1999-5delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 957,358 control chromosomes in the GnomAD database, including 1 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). The gene SCN8A is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0035 ( 1 hom., cov: 31)
Exomes 𝑓: 0.17 ( 0 hom. )

Consequence

SCN8A
NM_001330260.2 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.316

Publications

0 publications found
Variant links:
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
SCN8A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • developmental and epileptic encephalopathy, 13
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • cognitive impairment with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • seizures, benign familial infantile, 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile convulsions and choreoathetosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonus, familial, 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP6
Variant 12-51745885-CT-C is Benign according to our data. Variant chr12-51745885-CT-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 212134.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330260.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN8A
NM_001330260.2
MANE Select
c.1999-5delT
splice_region intron
N/ANP_001317189.1Q9UQD0-2
SCN8A
NM_014191.4
MANE Plus Clinical
c.1999-5delT
splice_region intron
N/ANP_055006.1Q9UQD0-1
SCN8A
NM_001177984.3
c.1999-5delT
splice_region intron
N/ANP_001171455.1Q9UQD0-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN8A
ENST00000354534.11
TSL:1 MANE Plus Clinical
c.1999-17delT
intron
N/AENSP00000346534.4Q9UQD0-1
SCN8A
ENST00000627620.5
TSL:5 MANE Select
c.1999-17delT
intron
N/AENSP00000487583.2Q9UQD0-2
SCN8A
ENST00000599343.5
TSL:5
c.2032-17delT
intron
N/AENSP00000476447.3Q9UQD0-3

Frequencies

GnomAD3 genomes
AF:
0.00348
AC:
496
AN:
142350
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00177
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00286
Gnomad ASJ
AF:
0.00182
Gnomad EAS
AF:
0.000402
Gnomad SAS
AF:
0.000224
Gnomad FIN
AF:
0.0144
Gnomad MID
AF:
0.00342
Gnomad NFE
AF:
0.00376
Gnomad OTH
AF:
0.00465
GnomAD2 exomes
AF:
0.244
AC:
19513
AN:
80108
AF XY:
0.258
show subpopulations
Gnomad AFR exome
AF:
0.190
Gnomad AMR exome
AF:
0.290
Gnomad ASJ exome
AF:
0.313
Gnomad EAS exome
AF:
0.241
Gnomad FIN exome
AF:
0.201
Gnomad NFE exome
AF:
0.228
Gnomad OTH exome
AF:
0.267
GnomAD4 exome
AF:
0.174
AC:
141659
AN:
814970
Hom.:
0
Cov.:
0
AF XY:
0.175
AC XY:
71493
AN XY:
407610
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.170
AC:
3086
AN:
18192
American (AMR)
AF:
0.190
AC:
4025
AN:
21236
Ashkenazi Jewish (ASJ)
AF:
0.199
AC:
2856
AN:
14322
East Asian (EAS)
AF:
0.189
AC:
4482
AN:
23662
South Asian (SAS)
AF:
0.192
AC:
9883
AN:
51418
European-Finnish (FIN)
AF:
0.181
AC:
5722
AN:
31682
Middle Eastern (MID)
AF:
0.103
AC:
392
AN:
3822
European-Non Finnish (NFE)
AF:
0.170
AC:
104977
AN:
616692
Other (OTH)
AF:
0.184
AC:
6236
AN:
33944
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.264
Heterozygous variant carriers
0
16723
33446
50169
66892
83615
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
3542
7084
10626
14168
17710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00350
AC:
498
AN:
142388
Hom.:
1
Cov.:
31
AF XY:
0.00377
AC XY:
261
AN XY:
69154
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00179
AC:
70
AN:
39124
American (AMR)
AF:
0.00286
AC:
41
AN:
14322
Ashkenazi Jewish (ASJ)
AF:
0.00182
AC:
6
AN:
3298
East Asian (EAS)
AF:
0.000403
AC:
2
AN:
4960
South Asian (SAS)
AF:
0.000450
AC:
2
AN:
4448
European-Finnish (FIN)
AF:
0.0144
AC:
125
AN:
8710
Middle Eastern (MID)
AF:
0.00373
AC:
1
AN:
268
European-Non Finnish (NFE)
AF:
0.00376
AC:
242
AN:
64418
Other (OTH)
AF:
0.00461
AC:
9
AN:
1952
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.349
Heterozygous variant carriers
0
35
69
104
138
173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00992
Hom.:
2

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.32
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs769940455; hg19: chr12-52139669; COSMIC: COSV61978474; COSMIC: COSV61978474; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.